M.D. Eric Aguiar - 17 Jun 2021 Form 4 Insider Report for BridgeBio Pharma, Inc. (BBIO)

Role
Director
Signature
/s/ Brian Stephenson, Attorney-in-Fact
Issuer symbol
BBIO
Transactions as of
17 Jun 2021
Net transactions value
$0
Form type
4
Filing time
22 Jun 2021, 18:45:15 UTC
Next filing
02 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BBIO Stock Option (right to buy) Award $0 +38,895 $0.000000 38,895 17 Jun 2021 Common Stock 38,895 $62.63 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests and becomes exercisable in three annual installments after June 17, 2021, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such date.